Literature DB >> 7977181

The continuity principle: a unified approach to disaster and trauma.

H Omer1, N Alon.   

Abstract

The continuity principle stipulates that through all stages of disaster, management and treatment should aim at preserving and restoring functional, historical, and interpersonal continuities, at the individual, family, organization, and community levels. Two misconceptions work against this principle and lead to decisional errors: the "abnormalcy bias" which results in underestimating victims' ability to cope with disaster, and the "normalcy bias" which results in underestimating the probability or extent of expected disruption. This article clarifies these biases and details the potential contributions of the continuity principle at the different stages of the disaster.

Entities:  

Mesh:

Year:  1994        PMID: 7977181     DOI: 10.1007/BF02506866

Source DB:  PubMed          Journal:  Am J Community Psychol        ISSN: 0091-0562


  4 in total

1.  Creating "a Safe Haven": Emotion-Regulation Strategies Employed by Mothers and Young Children Exposed to Recurrent Political Violence.

Authors:  Michal Gatenio-Kalush; Esther Cohen
Journal:  J Child Adolesc Trauma       Date:  2019-12-20

2.  Mental Health in Health Professionals in the COVID-19 Pandemic.

Authors:  Antonia Bendau; Andreas Ströhle; Moritz Bruno Petzold
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Recognising and responding to suicidal crisis within family and social networks: qualitative study.

Authors:  Christabel Owens; Gareth Owen; Judith Belam; Keith Lloyd; Frances Rapport; Jenny Donovan; Helen Lambert
Journal:  BMJ       Date:  2011-10-18

4.  Changing Emotions About Fukushima Related to the Fukushima Nuclear Power Station Accident-How Rumors Determined People's Attitudes: Social Media Sentiment Analysis.

Authors:  Shin Hasegawa; Teppei Suzuki; Ayako Yagahara; Reiko Kanda; Tatsuo Aono; Kazuaki Yajima; Katsuhiko Ogasawara
Journal:  J Med Internet Res       Date:  2020-09-02       Impact factor: 5.428

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.